MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2024 · 101 positions · Total reported value $2.69B · Top-10 concentration 44.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2024 13F filing, MONTANOVA CAPITAL, LLC disclosed 101 equity positions with a combined reported value of $2.69B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were SPY ($235.38M), BHVN ($218.93M), KURA ($150.80M). By sector, the heaviest allocations are Health Care 42.3%, Technology 12.8%. Versus the prior quarter, allocation shifted toward Other (+7.3pp), Communication Services (+1.3pp) and away from Financials (-0.9pp), Technology (-1.1pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q1 2024 were SPY ($235.38M), QQQ ($86.58M), KO ($33.43M).

Of the 14 positions fully exited versus the prior quarter, the largest were LVS ($36.33M), KWEB ($24.30M), AGIO ($8.90M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • SPY STATE STR SPDR S&P 500 ETF T · $235.38M
  • QQQ INVESCO QQQ TR · $86.58M
  • KO THE COCA-COLA CO · $33.43M
  • AAPL APPLE INC · $30.30M
  • CRH CRH PLC · $28.95M
  • AVBP ARRIVENT BIOPHARMA INC COM · $27.93M
  • FATE Fate Therapeutics Inc · $18.81M
  • CRM SALESFORCE INC · $16.58M

Fully Exited (vs previous quarter)

  • LVS LAS VEGAS SANDS CORP · prev qtr: $36.33M
  • KWEB KRANESHARES TRUST · prev qtr: $24.30M
  • AGIO AGIOS PHARMACEUTICALS INC · prev qtr: $8.90M
  • ANAB ANAPTYSBIO INC COM · prev qtr: $7.60M
  • SANA SANA BIOTECHNOLOGY INC · prev qtr: $6.55M
  • AZN ASTRAZENECA PLC · prev qtr: $4.75M
  • INCY INCYTE CORP · prev qtr: $2.36M
  • MRK MERCK & CO. INC. · prev qtr: $1.69M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 42.3%
Technology 12.8%
Financials 3.3%
Other 27.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 450.00K $235.38M 8.74%
8.74%
New
2 4.00M $218.93M 8.13%
8.13%
Reduce
3 7.07M $150.80M 5.60%
5.60%
Add
4 1.56M $108.66M 4.04%
4.04%
Reduce
5 195.00K $86.58M 3.22%
3.22%
New
6 173.60K $84.30M 3.13%
3.13%
Reduce
7 1.68M $78.29M 2.91%
2.91%
Reduce
8 7.88M $78.06M 2.90%
2.90%
Reduce
9 3.76M $77.80M 2.89%
2.89%
Reduce
10 6.30M $73.31M 2.72%
2.72%
Add
11 2.25M $68.34M 2.54%
2.54%
Reduce
12 959.20K $66.38M 2.46%
2.46%
Reduce
13 356.96K $64.39M 2.39%
2.39%
Reduce
14 341.70K $61.67M 2.29%
2.29%
Add
15 2.02M $54.88M 2.04%
2.04%
Reduce
16 137.14K $49.81M 1.85%
1.85%
Add
17 4.19M $49.72M 1.85%
1.85%
Add
18 1.18M $49.49M 1.84%
1.84%
Add
19 121.90K $47.99M 1.78%
1.78%
Add
20 5.11M $46.18M 1.72%
1.72%
Reduce
21 109.89K $45.90M 1.71%
1.71%
Hold
22 329.35K $44.81M 1.66%
1.66%
Reduce
23 2.40M $42.22M 1.57%
1.57%
Add
24 370.64K $41.68M 1.55%
1.55%
Reduce
25 169.28K $36.98M 1.37%
1.37%
Reduce
26 207.45K $36.41M 1.35%
1.35%
Reduce
27 546.50K $33.43M 1.24%
1.24%
New
28 79.32K $33.37M 1.24%
1.24%
Reduce
29 5.78M $32.65M 1.21%
1.21%
Hold
30 56.64K $30.41M 1.13%
1.13%
Reduce
31 176.68K $30.30M 1.12%
1.12%
New
32 335.58K $28.95M 1.07%
1.07%
New
33 1.56M $27.93M 1.04%
1.04%
New
34 2.85M $26.89M 1.00%
1.00%
Reduce
35 50.92K $26.41M 0.98%
0.98%
Reduce
36 196.67K $24.70M 0.92%
0.92%
Reduce
37 7.97K $23.17M 0.86%
0.86%
Reduce
38 914.48K $22.77M 0.85%
0.85%
Hold
39 1.52M $22.36M 0.83%
0.83%
Add
40 303.04K $20.75M 0.77%
0.77%
Reduce
41 2.56M $18.81M 0.70%
0.70%
New
42 957.30K $18.07M 0.67%
0.67%
Hold
43 78.50K $16.75M 0.62%
0.62%
Reduce
44 55.05K $16.58M 0.62%
0.62%
New
45 172.95K $15.81M 0.59%
0.59%
New
46 90.10K $14.25M 0.53%
0.53%
Hold
47 106.09K $14.18M 0.53%
0.53%
Reduce
48 395.85K $13.72M 0.51%
0.51%
New
49 3.65M $12.06M 0.45%
0.45%
Reduce
50 210.70K $10.24M 0.38%
0.38%
Add

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, MONTANOVA CAPITAL, LLC reported 101 equity positions worth $2.69B in aggregate; its largest disclosed positions were SPY ($235.38M), BHVN ($218.93M), KURA ($150.80M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $2.69B of long equity holdings across 101 positions as of 2024-Q1. Top-10 holdings account for 44.3% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →